+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 2
Age: 18Years +
All Genders
ID06806033

Optimizing Cytokine Release Syndrome Management with Glofitamab Alone or Combined with Gemcitabine and Oxaliplatin for RelapsedRefractory Aggressive B-Cell Non-Hodgkins Lymphoma

Led by Hoffmann-La Roche · Updated on 2026-10-09

130

Participants Needed

53

Research Sites

112 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating treatments for participants with relapsed or refractory aggressive B-cell Non-Hodgkins lymphoma in this Phase II trial. The study aims to optimize the cytokine release syndrome CRS profile when using glofitamab combined with gemcitabine and oxaliplatin Glofit-GemOx followed by glofitamab alone, as well as glofitamab monotherapy. An optimized steroid premedication and monitoring schedule allow these treatments to be given in an outpatient setting. Participants receive intravenous obinutuzumab one week before starting treatment. Those in Cohort A get glofitamab combined with gemcitabine and oxaliplatin for up to 8 cycles, then continue with glofitamab alone for up to 12 cycles, with each cycle lasting 21 days. Cohort B participants receive glofitamab alone for up to 12 cycles. Treatments are administered intravenously, and the study uses a non-randomized, open-label design. During the study, participants undergo regular monitoring for cytokine release syndrome and other adverse events for up to approximately 5 years. Researchers assess response rates, duration of response, progression-free survival, and overall survival. Safety is closely followed with standardized assessments, including imaging and laboratory tests. The study lasts several years, with long-term follow-up to observe treatment effects and safety.

CONDITIONS

Brief Title

Evaluate Optimization of CRS Profile for Glofit Monotherapy and Glofit+GemOx in R/R Aggressive B-NHL

Research Team

R

Reference Study ID Number: GO45434 https://forpatients.roche.com/ No attachments to email below.

F

Fastest response: use the inquiry form. https://www.gene.com/contact-us/submit-medical-inquiry

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here